Expensive-medicine access is full of terms that sound interchangeable but are not. A few words can determine which benefit pays, which product is allowed, where treatment can happen, and what kind of financial help is legal or available.
Medical benefit
The part of health coverage that pays for medical services and many clinician-administered medicines. Infusions and office-administered injections are commonly processed here.
Pharmacy benefit
The prescription-drug side of coverage. Retail, mail-order and specialty-pharmacy medicines commonly run here, though some clinician-administered products can be supplied through a specialty pharmacy.
Prior authorization
A plan review that must occur before certain medicines or services are covered. Approval is not a guarantee that every claim will pay; benefit, network, coding and member cost-sharing still matter.
Step therapy / preferred product
A rule that may require trying a preferred medicine or product first. In biologic families, a plan may prefer a biosimilar even when multiple products share similar indications.
Formulary
A prescription-drug list used mainly for pharmacy benefits. Medical-benefit drugs may instead be governed by medical policies, clinical program summaries or other payer criteria.
Biosimilar
An FDA-approved biologic that is highly similar to an FDA-approved reference product with no clinically meaningful differences in safety, purity and potency under the approved conditions of use.
Interchangeable biosimilar
A biosimilar that meets additional FDA interchangeability requirements. Interchangeability does not mean every insurer, state substitution law, prescriber workflow or indication is identical—verify the actual product and policy.
Site of care
The location where treatment is administered: physician office, infusion center, hospital outpatient department, home infusion or another setting. Some plans restrict or prefer certain sites.
Buy and bill
A common medical-benefit model in which the treatment site purchases the medicine, administers it, then bills the insurer for the drug and administration service.
Specialty pharmacy / white bagging
A plan may require a specialty pharmacy to dispense the medicine for delivery to a treatment site rather than allowing the site to buy and bill it. Policies and terminology vary.
HCPCS / J-code
HCPCS Level II codes identify many drugs, biologicals and services billed on medical claims. Many provider-administered drugs receive J-codes; some products use Q-, C-, A- or other codes.
NOC / unclassified code
A “not otherwise classified” or unclassified code may be used for a new drug before a permanent product-specific code is effective. Payer instructions and required claim details matter.
NDC
The National Drug Code identifies a particular labeled drug product/package. Some medical claims require NDC information in addition to the HCPCS code.
ASP
Average Sales Price is part of Medicare's payment methodology for many Part B drugs. It is a payment concept—not a promise of patient cost or coverage.
Coinsurance
A percentage of the allowed amount that the patient may owe after coverage rules are applied. For very expensive medicines, percentage-based cost sharing can become substantial.
Deductible
An amount the member may need to pay before the plan begins paying under the applicable benefit. Exact rules depend on the plan.
Medical necessity
A coverage standard defined by the payer or program. A medicine can be FDA-approved yet still require diagnosis, prior-treatment or other criteria to meet a plan's medical-necessity rules.
Denial / appeal
A denial is an adverse coverage or payment decision. The written reason determines the next move. Appeals or reconsiderations challenge the decision using the plan/program's formal process.
Copay card
Manufacturer assistance commonly designed for eligible commercially insured patients. Federal-program restrictions are important; do not assume Medicare, Medicaid or TRICARE patients can use one.
Independent foundation
A separate charitable organization that may provide disease- or treatment-related financial assistance. Fund openings and eligibility can change rapidly, which is why MedicineCostHelp links to current official status instead of promising a fund is open.
- Get the exact wording from the plan or treatment site.
- Open the current official source that controls that issue.
- Keep the exact medicine/formulation and benefit channel straight.
- Use the coverage action plan to organize the next administrative steps.